← Eichor
Condition: Epilepsy Treatment Refractory Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Epilepsy Treatment Refractory

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Network Effects of Therapeutic Deep Brain Stimulation
NA · 1 location(s) · The University of Texas Health Science Center, Houston · NCT05600738Evaluation of the Epilepsy-related Quality of Life, Seizure-related Accidents and Validation of the Mjn-SERAS Solution i
Phase N/A · 6 location(s) · MJN Neuroserveis, S.L · NCT05845255AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
Phase 1/Phase 2 · 18 location(s) · UniQure Biopharma B.V. · NCT06063850Cannabidiol as add-on Therapy for Children With Refractory Epilepsy (CBD-uN1que), a High-quality Individualized Approach
Phase 3 · 1 location(s) · UMC Utrecht · NCT07668856Optimizing Therapy in Epilepsy Using Seizure Forecasts Via EEG and Wearables
NA · 1 location(s) · Mayo Clinic · NCT07012148Treatment of Refractory Infantile Spasms With Fenfluramine
Phase 2 · 2 location(s) · Children's Hospital of Orange County · NCT04289467A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)
Phase 1/Phase 2 · 17 location(s) · Neurona Therapeutics · NCT06422923The Safety and Efficacy Evaluation of Everolimus as an Adjunctive Treatment for Focal Refractory Epilepsy
EARLY_Phase 1 · 1 location(s) · Xuanwu Hospital, Beijing · NCT07095933Self-administered ONe-of-a Kind Approach to Epilepsy Therapy Through a Web-based Music Application
NA · 2 location(s) · Dartmouth-Hitchcock Medical Center · NCT06425029Percutaneous Repair for Drug - Resistant Epilepsy by Intervention of Closing the Patent Foramen Ovale（PREDICT-PFO Trial）
NA · 1 location(s) · Sichuan University · NCT06863350The Efficacy of a Subanesthetic Doses of IV Ketamine in the Treatment Drug Resistant Epilepsy
Phase 2 · 1 location(s) · Madeline Fields · NCT05019885Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
Phase N/A · 16 location(s) · Epiminder America, Inc. · NCT07110454Treatment With Full-spectrum Cannabis Extract of Refractory Epilepsy Associated With Tuberous Sclerosis Complex (TSC)
Phase 3 · 1 location(s) · Oils4Cure · NCT07403266Surgery as a Treatment for Medically Intractable Epilepsy
Phase N/A · 1 location(s) · National Institute of Neurological Disorders and Stroke (NIN · NCT01273129Sirolomus Adjuvant Treatment of Focal Refractory Epilepsy (SATFRE)
EARLY_Phase 1 · 1 location(s) · Xuanwu Hospital, Beijing · NCT06719791Non-Invasive Low Intensity Focused Ultrasound Stimulation for Drug-Resistant Epilepsy
NA · 1 location(s) · University of California, San Francisco · NCT07680842Diagnosing Epilepsy To EffeCT Change
NA · 19 location(s) · Epiminder America, Inc. · NCT07110337Ketogenic Diet for Prevention of Epileptic Spasms in Infantile Onset Genetic Epilepsies
Phase 1 · 1 location(s) · Heather Olson · NCT06700811
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.